Endpoints News ٢٤ نوفمبر ٢٠٢٥ J&J’s tau-targeting antibody fails Phase 2 Alzheimer's study #fails Phase #Alzheimer study
Endpoints News ٢١ نوفمبر ٢٠٢٥ Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial #Thursday afternoon #fails Phase